Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

Patrick S. Sullivan(Emory University), Lucy E. Cottle, E. Piwowar-Manning, Meredith E. Clement(Louisiana State University Health Sciences Center New Orleans), Edgar T. Overton(University of Alabama at Birmingham), Christina Psaros(Harvard University), Breno Santos(Hospital Nossa Senhora da Conceição), S. Safren, Z. Wang, M.S. Cohen(University of North Carolina at Chapel Hill), Katherine Shin, Timothy H. Holtz(Centers for Disease Control and Prevention), Keren Middelkoop(Desmond Tutu HIV Foundation), William Spreen(Unknown), J.J. Eron, S. Chariyalertsak, Aditya H. Gaur(St. Jude Children's Research Hospital), R. Cabello, Craig W. Hendrix(Unknown), Nirupama Sista(Family Health International 360), A. Rinehart, A. Jennings, Omar Sued(Fundación Huésped), A. Adeyeye, Ian Frank(Norwegian Womens Public Health Association), R. Kofron, Hyman Scott(UCLA Medical Center), Lara E. Coelho(UCLA Medical Center), S.H. Eshleman, B. Grinsztejn, Mersine A. Bryan(University of Washington), M. McCauley, Marcelo Losso(UCLA Medical Center), R.J. Landovitz, D. Donnell, Mark A. Marzinke(Family Health International 360), Eric S. Daar(UCLA Medical Center), Colleen F. Kelley(Emory University), Brett Hanscom(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), J. Lucas, Juan Hinojosa(Asociación para la Conservación de la Cuenca Amazónica), Patrick Gonzales, Shelly Fields, CM Blanchette(University of North Carolina at Charlotte), Peter K Anderson, Aida Asmelash(Family Health International 360), Jorge A. Gallardo-Cartagena(National University of San Marcos), Paul A. Richardson(Johns Hopkins University), HPTN Study Team
UNC Libraries
November 17, 2023
Cited by 0


Related Papers